Inhalation aid
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a top perspective view of an inhalation aid showing my new design;
FIG. 2 is a rear elevational view thereof;
FIG. 3 is a front elevational view thereof;
FIG. 4 is a side elevational view thereof, the opposite side elevational view being identical thereto;
FIG. 5 is a top plan view thereof, and
FIG. 6 is a bottom plan view thereof.
Referenced Cited
U.S. Patent Documents
D262320 | December 15, 1981 | Mono D24 62 |
Patent History
Patent number: D313850
Type: Grant
Filed: Jun 3, 1988
Date of Patent: Jan 15, 1991
Assignee: Glaxo Group Limited (London)
Inventor: Robert E. Newell (Pinner)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella M. Reid
Law Firm: Darby & Darby
Application Number: 7/202,438
Type: Grant
Filed: Jun 3, 1988
Date of Patent: Jan 15, 1991
Assignee: Glaxo Group Limited (London)
Inventor: Robert E. Newell (Pinner)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella M. Reid
Law Firm: Darby & Darby
Application Number: 7/202,438
Classifications
Current U.S. Class:
D24/62